We are live on
!
Find out more
RI
RTW Investments Portfolio holdings
AUM
$10B
1-Year Est. Return
135.35%
This Fund
S&P 500
This Quarter
Est. Return
+13.47%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$10B
AUM Growth
+$66.4M
(+0.67%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
4.17%
Top 10 Holdings %
Top 10 Hldgs %
49.99%
Holding
98
New
7
Increased
30
Reduced
13
Closed
10
Top Buys
| 1 |
CG Oncology
CGON
|
+$282M |
| 2 |
Celcuity
CELC
|
+$271M |
| 3 |
Erasca
ERAS
|
+$189M |
| 4 |
Tango Therapeutics
TNGX
|
+$164M |
| 5 |
iRhythm Holdings
IRTC
|
+$70.2M |
Top Sells
| 1 |
Penumbra
PEN
|
+$269M |
| 2 |
Axsome Therapeutics
AXSM
|
+$162M |
| 3 |
Insulet
PODD
|
+$92.3M |
| 4 |
MASI
Masimo
MASI
|
+$88.9M |
| 5 |
APLS
Apellis Pharmaceuticals
APLS
|
+$85.8M |
Sector Composition
| 1 | Healthcare | 99.92% |
| 2 | Financials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVMN
51
Evommune Inc
EVMN
$422M
| $34.5M | 0.34% |
1,502,235
+218,564
| +17% | +$4.94M |
|
52
Stryker
SYK
$127B
| $32.9M | 0.33% |
100,000
-145,000
| -59% | -$52.1M |
|
53
Savara
SVRA
$1.13B
| $32.5M | 0.32% |
5,952,380
| – | – |
|
54
Candel Therapeutics
CADL
$695M
| $31.5M | 0.31% |
+6,422,018
| New | +$34.9M |
|
55
Aquestive Therapeutics
AQST
$494M
| $30.8M | 0.31% |
7,426,471
+1,176,471
| +19% | +$4.77M |
|
|
AKTS
56
Aktis Oncology
AKTS
$1.38B
| $28.5M | 0.28% |
+1,592,043
| New | +$30.9M |
|
57
Neurogene
NGNE
$728M
| $27.5M | 0.27% |
1,362,456
| – | – |
|
58
Cullinan Oncology
CGEM
$1.01B
| $24.2M | 0.24% |
1,705,960
| – | – |
|
59
Compass Therapeutics
CMPX
$378M
| $22.1M | 0.22% |
4,186,599
+1,686,599
| +67% | +$9.74M |
|
60
Dianthus Therapeutics
DNTH
$5.21B
| $20.8M | 0.21% |
+248,063
| New | +$14.4M |
|
61
Fulgent Genetics
FLGT
$584M
| $20.5M | 0.2% |
1,289,000
+583,973
| +83% | +$12.7M |
|
|
BBNX
62
Beta Bionics
BBNX
$753M
| $20M | 0.2% |
2,000,000
-500,000
| -20% | -$7.4M |
|
63
Kymera Therapeutics
KYMR
$9.38B
| $20M | 0.2% |
240,000
| – | – |
|
64
Century Therapeutics
IPSC
$408M
| $19.7M | 0.2% |
+8,695,652
| New | +$18.3M |
|
65
Beam Therapeutics
BEAM
$2.92B
| $13.6M | 0.14% |
570,394
| – | – |
|
66
Avalo Therapeutics
AVTX
$940M
| $12.8M | 0.13% |
+856,962
| New | +$13.4M |
|
67
Ocugen
OCGN
$464M
| $12.1M | 0.12% |
+6,666,666
| New | +$11.5M |
|
|
HTFL
68
Heartflow Inc
HTFL
$2.24B
| $12M | 0.12% |
495,000
| – | – |
|
69
Wave Life Sciences
WVE
$1.09B
| $9.79M | 0.1% |
1,350,000
| – | – |
|
|
PCSC
70
Perceptive Capital Solutions
PCSC
$124M
| $8.15M | 0.08% |
742,500
| – | – |
|
|
JBIO
71
Jade Biosciences
JBIO
$1.25B
| $8.05M | 0.08% |
573,205
-876,068
| -60% | -$12.7M |
|
72
Capricor Therapeutics
CAPR
$1.11B
| $7.6M | 0.08% |
250,000
| – | – |
|
73
Milestone Pharmaceuticals
MIST
$154M
| $7.53M | 0.08% |
6,331,001
+3,824,899
| +153% | +$6.7M |
|
|
KLRS
74
Kalaris Therapeutics
KLRS
$110M
| $7.5M | 0.07% |
1,300,000
| – | – |
|
|
IVA
75
Inventiva
IVA
$1.07B
| $7.21M | 0.07% |
1,298,702
+1
| +0% | +$6 |
|
Similar funds
BEI
MG
LWCFA
HRCM
RA
VNIM
OAM
GI